SIX1 Downregulation Suppresses Self-renewal Capacity and THY1 Expression in Hepatocellular Carcinoma and SIX1 Dominate the Survival in Liver Cancer

dc.contributor.authorBalcik-Ercin, Pelin
dc.contributor.authorAysan, Arzu
dc.contributor.authorSalik, Nazli
dc.contributor.authorErciyas, Esma
dc.date.accessioned2025-10-29T11:08:01Z
dc.date.issued2023
dc.departmentFakülteler, Temel Bilimler Fakültesi, Moleküler Biyoloji ve Genetik Bölümü
dc.description.abstractBackground/Aims: Sine oculis homeoprotein 1 exerts an essential role in embryonic development, and it was also identified to be reactivated in various types of mammalian cancer. The sine oculis homeoprotein 1 transcription factor was demonstrated to induce epithelial-mesenchymal transition, regulate crucial genes associated with cancer progression, and increase the oncogenic potential of cells. Therefore, the present study aimed to identify the role of sine oculis homeoprotein 1 in cancer. Materials and Methods: Sine oculis homeoprotein 1 gene expression was tested with real-time quantitative polymerase chain reaction (PCR) in different cancer types. Sine oculis homeoprotein 1 expression was suppressed by short hairpin RNA transduction in the SNU398 hepatocellular carcinoma cell line. The effects of sine oculis homeoprotein 1 on cell proliferation, drug resistance, and sphere formation were assessed in shSIX1 cells. Immunohistochemical and in silico analyses were performed to determine the prognostic role of sine oculis homeoprotein 1 expression. Results: The upregulated expression levels of sine oculis homeoprotein 1 were revealed to be correlated with the stage of the disease in breast, colon, and liver cancer, with liver cancer exhibiting the highest expression profile. Sine oculis homeoprotein 1 downregulation significantly affected cell proliferation and suppressed sorafenib resistance and sphere-forming ability. Furthermore, sine oculis homeoprotein 1 knockdown cells were identified to have decreased CD90 levels, essential for cancer stem cell properties. Finally, sine oculis homeoprotein 1 expression was a CD90-independent biomarker for the clinical prognosis of liver cancer. Conclusion: The results of this study showed that the knockdown of sine oculis homeoprotein 1 expression might help to prevent hepatocarcinogenesis by increasing drug sensitivity and controlling tumor sphere formation. Overall, these results indicated that sine oculis homeoprotein 1 expression might be useful as a diagnostic marker for patients with hepatocellular carcinoma.
dc.identifier.doi10.5152/tjg.2023.22293
dc.identifier.endpage889
dc.identifier.issn2148-5607
dc.identifier.issue8
dc.identifier.orcid0000-0002-3470-0393
dc.identifier.orcid0000-0001-7217-3347
dc.identifier.pmid37427884
dc.identifier.scopus2-s2.0-85166442669
dc.identifier.scopusqualityQ3
dc.identifier.startpage881
dc.identifier.trdizinid1241558
dc.identifier.urihttps://doi.org/10.5152/tjg.2023.22293
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1241558
dc.identifier.urihttps://hdl.handle.net/20.500.14854/5155
dc.identifier.volume34
dc.identifier.wosWOS:001109157300012
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAves
dc.relation.ispartofTurkish Journal of Gastroenterology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20251020
dc.subjectSIX1
dc.subjecthepatocellular carcinoma
dc.subjectdrug response
dc.subjectCD90
dc.subjectsurvival
dc.titleSIX1 Downregulation Suppresses Self-renewal Capacity and THY1 Expression in Hepatocellular Carcinoma and SIX1 Dominate the Survival in Liver Cancer
dc.typeArticle

Dosyalar